Table 2. Regression model coefficient point estimates (95% CI) for models of VA outcomes as a function of ALS disease variables with control subjects assumed to have no limitations.
Visual acuity outcome | Functional impairment (48-ALSFRS-R) | Functional impairment (MMT) | Disease duration (years) |
---|---|---|---|
100% HCVA | -0.10 (-0.32, 0.11) | -0.01 (-0.09, 0.10) | 0.24 (-0.74, 1.22) |
p = 0.35 | p = 0.93 | p = 0.63 | |
2.5% LCVA | -0.15 (-0.50, 0.21) | -0.04 (-0.21, 0.17) | -0.71 (-2.95, 1.53) |
p = 0.41 | p = 0.68 | p = 0.53 | |
1.25% LCVA | -0.30 (-0.61, 0.02) | -0.04 (-0.19, 0.12) | -1.92 (-3.42, -0.42) |
p = 0.07 | p = 0.64 | p = 0.01 |
HCVA: high contrast visual acuity, LCVA: low contrast visual acuity, ALSFRS-R: amyotrophic lateral sclerosis functional rating score with respiration, MMT: manual motor testing,
Coefficients are from generalized estimating models of monocular VA accounting for age and within subject correlation